ArticlePolymers2025
Crown Ether-Functionalized Polyethersulfone Membranes with Potential Applications in Hemodialysis.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Physicochemical, Mechanical, and Histological Assessment of Explanted Polypropylene Meshes from Recurrent Abdominal Wall Hernia Repairs.Materials (Basel, Switzerland) · 2026Article
- Covalent Immobilization of Crown Ether on Cellulose Acetate Membranes for Enhanced Heavy Metal Ion Retention.Polymers · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polyethersulfone (PES) is one of the most used synthetic polymers for the production of hemodialysis membranes, due to its appropriate features, such as biocompatibility, high permeability for low-molecular-weight proteins, high endotoxin retention ability, and resistance to sterilization processes. However, there is room for improvement regarding their anticoagulant properties when coming into contact with blood. In the present study, commercial PES membranes were plasma-treated and then chemically modified with crown ether, an organic compound that could interfere with the coagulation cascade by complexating Ca
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.